Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 41.28% is 109% above its 4-year average of 19.72%, near the high end of its 4-year range (14.96%–42.52%).
As of the fiscal period ended Tuesday, June 30, 2026. 26.39% above its 12-month average of 32.66%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 41.28%.
DEBT TO ASSETS RATIO
41.28%
DEBT TO ASSETS RATIO AVG TTM
32.66%
DEBT TO ASSETS RATIO AVG 3Y
24.83%
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+26.39%
CURRENT VS 3Y AVG
+66.26%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 805 covered companies
CURRENT VS SECTOR MEDIAN
+45768.25%
vs the sector median at left
Indivior Pharmaceuticals Inc
Market Cap
$4.40B
Debt to Assets Ratio
41.28%
TTM Avg
32.66%
3Y Avg
24.83%
5Y Avg
N/A
Market Cap
$4.42B
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.44B
Debt to Assets Ratio
0.64%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.26B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.64B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.66B
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.68B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Indivior Pharmaceuticals Inc (INDV) | $4.40B | 41.28% | 32.66% | 24.83% | N/A |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.42B | 0.08% | N/A | N/A | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.44B | 0.64% | N/A | N/A | N/A |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.26B | 0.01% | N/A | N/A | N/A |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.64B | 0.03% | N/A | N/A | N/A |
| LivaNova PLC (LIVN)vs › | $4.15B | 0.13% | N/A | N/A | N/A |
| Option Care Health, Inc. (OPCH)vs › | $4.66B | 0.38% | N/A | N/A | N/A |
| BillionToOne, Inc. (BLLN)vs › | $4.68B | 0.20% | N/A | N/A | N/A |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.68B | 0.00% | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.68B | 0.09% | N/A | N/A | N/A |
Debt/Assets
41.3%
Debt/Equity
N/A
Current Ratio
0.84
Interest Coverage
5.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 41.28% |
| 2026-03-31 | 42.52% |
| 2025-12-31 | 29.15% |
| 2025-09-30 | 25.14% |
| 2025-06-30 | 25.21% |
| 2025-03-31 | 26.91% |
| 2024-12-31 | 28.43% |
| 2024-09-30 | 19.40% |
| 2024-06-30 | 18.31% |
| 2024-03-31 | 19.20% |
| 2023-12-31 | 16.03% |
| 2023-09-30 | 14.96% |
| 2023-06-30 | 16.23% |
| 2023-03-31 | 15.90% |
| 2022-12-31 | 15.57% |
| 2022-09-30 | 16.52% |
| 2022-06-30 | 16.28% |
| 2022-03-31 | 16.36% |
| 2021-12-31 | 15.61% |
